Skip to main navigation Skip to search Skip to main content

Endocarditis caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae: Emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility

  • Oren Zimhony*
  • , Inna Chmelnitsky
  • , Rita Bardenstein
  • , Sorel Goland
  • , Orly Hammer Muntz
  • , Shiri Navon Venezia
  • , Yehuda Carmeli
  • *Corresponding author for this work
  • Hadassah University Medical Centre
  • Tel Aviv Sourasky Medical Center

Research output: Contribution to journalArticlepeer-review

60 Scopus citations

Abstract

Three episodes of bacteremia occurred in the course of prosthetic valve endocarditis caused by an extended-spectrum-β-lactamase (ESRL)-producing Klebsiella pneumoniae strain. The second isolate developed resistance to ciprofloxacin and the third isolate to piperacillin-tazobactam (PIP-TZ) following sequential therapy with each agent. The first isolate was resistant to PIP-TZ only at high inocula, the second isolate acquired increased transcription of the acrA gene, and the third isolate became resistant to PIP-TZ due to loss of β-lactamase inhibition by TZ. We question if and how PIP-TZ susceptibility should be reported for ESBL-producing Enterobacteriaceae.

Original languageEnglish
Pages (from-to)3179-3182
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume50
Issue number9
DOIs
StatePublished - Sep 2006
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Endocarditis caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae: Emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility'. Together they form a unique fingerprint.

Cite this